Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
yah, gues it was since 12/06 (i think), but still, 4 consecutive days of steady increases and a new 52 week high yest
BIG DAY - New 52-week high on the strongest volume so far in 2010. Any thoughts for what's in store tomorrow?
Glycemic (i.e. blood sugar) levels are a “vital sign” for Diabetics and failure to accurately monitor them can results in a plethora of chronic health conditions. Did you know that someone dies from Diabetes-related complications every 10 seconds? How about that fact that the same number of people die annually from Diabetes as from HIV & AIDS?
Clearly, the need to improve quality of life for those afflicted is a MAJOR priority for the healthcare industry. This presents a prime opportunity for Echo Therapeutics to help improve life for millions of people just like the company's mentioned above.
The company's core focus – Glucose Control – is widely viewed as one of, if not the biggest, factors in reducing risk for sufferers. Aside from death, a Diabetic loses a leg every 30 seconds somewhere in the world and 85% of these amputations could be prevented through improved care, part of which includes tighter glycemic control.
Were about to close at a new 52-week high on the best volume since 12/06. Look out tomorrow because this stock is on a major run!
Demand: By the Numbers: Currently, continuous blood glucose monitoring systems are largely viewed as “generic”. While demand for said devices remains quite brisk and is expected to grow significantly over the next few decades – especially in medical facility environments – not much has come along recently with regard to product differentiation that has prompted end-users to demand a particular product.
Echo Therapeutics, Inc. holds the potential to change all of this and in turn command a sizable share of the BGM market with its upcoming release of the first ever needle-free “trans-dermal” system. Let's take a look at the current state of the target market for Echo's Symphony device and where it is poised to go over the next 5 to 6 years.
Is today the highest trading volume in ECTE history? It appears to be quite close. Vol has risen 4 consecutive days. With management striving to "uplist", I'm hoping that gains above $2 can be held over the near-term.
Were at $2. Very bullish move, in my opinion
Boenning and Scattergood slapped a near-term target of $3 on this stock. Any thoughts? We seem to be testing resistance at $2. Would love to see it bust through today.
"All of the top-rated stocks in history share one common characteristic: A product or service breakthrough that improves life for a significant percentage of the world. As I've stated in recent editions, Echo Therapeutics, Inc. (OTCBB: ECTE) is on the cusp of such a breakthrough. The company is poised to revolutionize the multi-billion dollar Diabetes care market in 2010 with its release of the first ever needle-free continuous blood glucose monitor (CBGM)."
Looks like its breaking out here! Very bullish activity early on today, folks.
I've put together some commentary on Echo's key target market - Diabetes Care - and Continuous Blood Glucose Monitoring, and will share it a bit later in the day once it gets published.
Wow, though. Very excited to see where this goes today.
These guys want to achieve AMEX listing and use that to springboard onto a more senior exchange. So, this makes $2 a pretty certain reality pending no unforeseen roadbumps to it gaining FDA approval for its Symphony product.
Were already up about $.50 since the beginning of December. Another $.30 would represent a very bullish move in recent months, but I think it could be achievable given the company's need to up-list.
I'd imagine that AMEX listing or better would be extremely helpful for Echo as it looks to secure financing and establish business relationships with leading global healthcare firms. The first product has multi-billion dollar potential and listing on a senior exchange would certainly give the company added credibility.
If I were the company, I'd be doing everything possible to boost PPS to >$2. Since these guys are considerably more intelligent than I, I think its pretty safe to say they're on it. Just my .02.
Any opinions on what impact the upcoming 2009 10K will have on PPS?
How about the $10 mil in equity financing? Excitement about the potential for buyouts, huge ad campaigns & sponsorship, and new R&D initiatives; Or Skepticism about potential dilution?
I gotcha. Yes, the CEO is very impressive in addition to the company's offering and near-term potential.
Looking at some close comps - as mentioned in the CEO interview - like Dexcom leads me to believe that Echo could mature significantly if it stays on track with plans to bring at least 1 FDA approved medical device to the public in 2010.
From where I see, ECTE is one FDA-Approval and one or two licensing agreements away from being a $5 stock or higher. I really hate to speculate on PPS increases, but that seems fair to me considering that the Symphony CBGM system would be the first needle-free system (i.e. a revolutionary product with a massive and growing addressable market) available to check Diabetic blood sugar/glucose, etc.
Any thoughts?
I'm going to try to attempt to develop some growth scenarios for Echo over the next 1 to 5 years. I think it would be really interesting to examine the potential for sales improvement and PPS increase as the company potentialy releases multiple FDA-approved medical device products.
Its going to take a bit of back of the napkin calculations and rough "guesstimates" on how many licensing agreements Echo will ink going forward and what the compensation structure is for each. But, I think I can get a pretty close idea of where things could go with Zero (this seems highly unlikely today), One, and Two products to market. Forecasting income for a 3rd potential product is tough because we don't even know which market it will target.
For the record, mgt. has stated that the total market opportunity for its first two products is >$15 billion, the lion's share be attributable to continuous blood glucose monitoring for Diabetics.
Any feedback or suggestions for variables in my analysis will be warmly welcomed and incorporated so long as they make sense.
So, you conducted the interview?
The interview is very promising, in my opinion. Management expects to have one or two FDA-approved products by the end of 2010 and these products have the potential to be very successful because they are needle-free (transdermal) alternatives to today's products.
Media coverage on SNWT:
http://meltwaternews.com/b.asp?u=418845&r=18688650
Please let me know if this works, folks!
The $10 million funding could help SNWT make another acquition similar to the County Imports deal, which is already paying off in a major way. One month internet sales driven by CI allowed the company to nearly log the same level of sales generated during Q3, which were a loft 54% higher tha the prior year period.
CI sales are higher now than they were this time last year during the company's all-time record year. In addition, this is typically CI's slowest season of the year. Mgt. will likely log County Imports revs in the $4M range in 2010, not too shabby.
If this money helps SNWT scoop up a watersports biz (PWCs are set to rebound in 2010 and there's a ton of companies just waiting to be scoooped up on the cheap, many of which could generate anywhere from $2 to $10M next year. With boat show season on the horizon, this has me excited as a long-term shareholder.
SNWT is striving to build an off-road superstore. So there's a multitude of avenues they could tread for acquistions going forward. Most firms in their line of biz don't have the luxury of having $10M in funding at their fingertips. This potential coupled with the fact that Q4 will be by far the best in corporate history and future growth potential is very promsing.
All in all, this is positive. Sure, equity financing is always an issue from a dilution standpoint. But, if SNWT can make their payments, which shouldnt be an issue given their steadily rising record sales, this will be a very useful source of capital.
The Dutchess guys are pretty savvy and likely have some ideas of their own pertaining to potential acquisiton targets. They want to ensure that they get a maximum return on their investment, employ some very bright minds and have transformed into more of a VC fund rather than a PIPE financier.
With the economic climte being what it is, many emerging small caps like SNWT would kill for this type of deal. Up nearly 20% today, here's to a solid Power Hour and close!
Big news out this morning.
Here you go, you research sleuth, you. The forward split went effective 11/3/09. Hence the one-day move in price from $1.05 to $.35 at the open of trading the next day.
"San West, Inc. Announces 5-for-1 Forward Split Record Date Set for Close of Business October 26th:
http://finance.yahoo.com/news/San-West-Inc-Announces-5for1-iw-858710476.html?x=0&.v=1
So, we are currently at about $.73, non-split adjusted. From about a penny a share since they hauled things in after prevailing in the Human Biosystems reverse merger, that's a pretty nice gain. If you look at the appreciation from around a penny to the 52-week high, you are looking at one of the best microcap growth stories of 2009.
Also, I find it quite interesting that you could find info on a reverse merger under the old ticker -HBSY- yet could not find the PR from a forward split that happened a bit more than a month ago.
Based on the operations of the previous company. Very common practice to haul things in right after or before a reverse merger.
There was a FORWARD SPLIT a few months ago!
There are no signs of a reverse, that is a complete FARCE!
When San West became a public company, there was a reverse, but that was soley based on the performance of Human BioSystems (the compnay snwt merged into).
Since then, the stock has risen from about a penny to roughly $1.70. Also, SNWT sales are the best in the company's history and the continue to add on new high margin revenue streams. So, I would say that a RS would not likely be in order. Don't you think?
No, you are correct. Does not look like profit taking. All of the longs I know - and I know alot of them - are still holding.
Unfortunately, I think some of the MMs and the shorts are the same. They will make a mint shorting this, walking it down and covering, and then making money on the way back up.
I share your sentiment that hopefully they get what they want soon. A little good news would sure go a long way here.
Hopefully, this scare tactic does'nt chase away some of the investors that truly believe in the growth story unfolding here. It would scare me off, that's for sure. For those of us with a little dough in the trading account to play with, these dips, as distressing as they may be, will likely create a nice entry point when we look back on this week a few months from now.
Good day and happy holidays.
Excellent point and very well articulated.
Sure is. I'd love to see some financial-related press hit the wire sometime soon. Don't think the crook MMs could hold it below .26 then.
I'll tell ya one thing though, someone is going to cash in greatly on all the shares scooped up over the past few weeks of .22 to .26 range trading if/when the stock makes another run. Besides of course the folks making the slow but steady gains walking it down to .22 again and again.
On another note, have we been on the air yet - on the price is right? I was watching today (east coast)and didnt see any buggies. I'll take Bob Barker over Drew Cary anyday. That's just me, though. Pretty sure he could still win in a fight despite his ripe old age. After the way he handled Adam Sandler in Happy Gilmore, my bets on him. OK I'm getting off track.
Here's to a green close today. Cheers!
"ECTE Inches Higher"
"Echo Therapeutics, Inc. (OTCBB: ECTE) moved higher on Wednesday, gaining 1.45% or $.02 on 42,950 shares traded. While the recent trading activity has been intriguing, the future potential of the company is what really has us hooked. As mentioned in yesterday’s analyst report, Echo is positioned to dominate the global diabetic monitoring marketplace with its revolutionary needle-free system. The company also has a multitude of additional opportunities at its fingertips."
http://www.outcasttrader.com/ecte-inches-higher/
Right on, brutha.
Dude, the stock is up from a penny to $1.25, post-split. It cant go up 50% every month.
Certainly,it has been sideways for a few weeks now, and if you want out, someone (like me) will surely scoop up your holding at .21 or below if you dont have the patience. Not trying to be a jerk at all. Stop losses are absolutely a key part of trading and you would be prudent in getting out if it hits your loss target if that happens to be below .22. Everyone's profit and loss levels are different.
For your own sake, though, just make sure you are playing on technicals and not emotions. Believe me, the inability to break .26 is irking me too, but I do see some light at the end of the tunnel when Q4 earnings are released. It would just be a shame to get out and chase it down the road.
Again, just my two cents. Best of luck to ya.
Boenning & Scattergood issued an outperform rating today with a 12-month price target of $3.
Excerpt from the report:
"In the next three years, Echo Therapeutics, Inc. has the potential of changing the way critical care physicians and nurses, endocrinologists and diabetics view glucose monitoring.
In 2003,Echo Therapeutics completed its first glucose monitoring pilot study using its first generation skin permeation system and glucose flux sensor. Since that time, Echo Therapeutics has developed a smaller, more advanced skin permeation system, the Prelude™ SkinPrep system. If its clinical trials are as positive as its pilot studies, Echo Therapeutics has an opportunity to become the market leader in the continuous glucose monitoring market."
Great news post market yesterday and we are testing .26 again this morning. Almost a million shares traded already, that has to be some kind of record for SNWT.
I think I'm going to become a moderator here and bring some eyeballs to the board as well as the company. This looks like a ground level opportunity here with a company that could tap into the diabetes diagnostics marketplace.
Surely, there's a major risk associated with investing in a firm with drugs and medical devices that are not yet mass-produced and FDA-approved. However, you won't find any companies with available, approved products trading in the <$5 range, let along under $2.
The "blue sky" here is extremely compelling and has me willing to research the company and its potential over the next few months.
I will speak with management ASAP and report back with anything interesting that I learn as well as some of the highlights of my Due Diligence.
you guys want to make money, don't sell below .26. MMs trying to walk this down slowly. don't hit the .23 bid. They'll keep swallowing up cheap shares and selling them back for a small gain foreever if we let them.
This is where the market makers try to take it back down to .24 or lower. Don't fall into their trap.
Obviously, this is just my opinion. But, the patterns seem evident to me after seeing this over the past few days.
We're knocking on .26, which will open the door to higher highs. The big players know this and are trying to get as much as possible below this level.
We all saw some of the old short posters resurface yesterday to create panic just as they did around the time of the forward split. My guess is they try to stir up panic to get a lower price or are working for someone with this agenda.
Holding below .30 for now here. Good luck to the longs!
here we are at.26.
Let's "break on through to the other side"
I hear ya, bro. Gotta be careful with your dough. But, that's (premie stop loss) what the thief MMs want. Tread cautiously, but hopefully well blast through .26 and form a new, higher base and we won't need to worry by week's end.
Good luck to ya. Stay strong. Stay up.
See how they walked this down late yesterday and then let it run back up and profited the whole way back? Down let em do it to us again.
Nice movement this morning, folks! Let's break .26 today, should have some nice room for profits a between there and .31 or so.
Won't take much from here to bust through resistance and test the next, higher level.
Hope the shorties that were fishing around yesterday are already feeling the pressure of antoher squeeze.
Good luck longs!
Anybody out there?
Morning board!
So, how many shares you short? Down big from the last squeeze or a new position?
I would hope that anybody willing to risk their own hard-earned money investing in SNWT would be capable of conducting the same Sherlock-esque investigative reporting that you did and reading the SEC filings. Nice find, man. Seriously. You gonna charge us for your analysis and the first brief is free, or...?
At least this guy has a past history of posting on other boards unlike most of the other negative posters that pop up when short interest picks up and then crawl back into the woodwork after a squeeze.